NCT00779558View on ClinicalTrials.gov

Heparin and the Reduction of Thrombosis (HART) Trial

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Thrombosis
Interventions
DRUG

Heparin sulfate infusion at 10 units/kg/hour

Infusion of heparin to prevent central line thrombosis in infants after cardiac surgery

DRUG

Placebo infusion

Infusion of normal saline

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT00779558 - Heparin and the Reduction of Thrombosis (HART) Trial | Biotech Hunter | Biotech Hunter